Followers | 3817 |
Posts | 152166 |
Boards Moderated | 4 |
Alias Born | 08/05/2009 |
Recent EVAX News
- Evaxion Partners With Pharmaceutical Company Afrigen Biologics to Develop Novel mRNA Vaccine Against Gonorrhea • GlobeNewswire Inc. • 09/20/2023 12:26:00 PM
- Evaxion expands preclinical bacterial vaccine pipeline in collaboration with leading pharmaceutical company • GlobeNewswire Inc. • 09/18/2023 12:23:00 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 09/13/2023 08:45:24 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/11/2023 12:17:07 PM
- Revolutionizing Vaccine Discovery: New Data Validates Evaxion AI Platform, Offering Promise to Reduce Risk and Cost in Infectious Disease Vaccine Development • GlobeNewswire Inc. • 09/11/2023 12:17:00 PM
- Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend] • Edgar (US Regulatory) • 09/07/2023 08:45:04 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/31/2023 04:15:12 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/29/2023 01:22:42 PM
- Evaxion announces Executive Management Changes to strengthen the AI-strategy • GlobeNewswire Inc. • 08/29/2023 12:30:00 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 08/25/2023 09:00:53 PM
- Evaxion Announces Business Update and Second Quarter 2023 Financial Results • GlobeNewswire Inc. • 08/18/2023 03:57:08 PM
- Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend] • Edgar (US Regulatory) • 08/18/2023 01:28:59 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/17/2023 08:58:50 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/17/2023 08:45:16 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/11/2023 08:45:16 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/04/2023 08:45:24 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/01/2023 11:00:06 AM
- Evaxion announces financing commitments totaling up to USD 20 million with Negma Group • GlobeNewswire Inc. • 08/01/2023 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/31/2023 08:45:09 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/31/2023 11:00:07 AM
- Evaxion presents promising results on EVX-B1, an AI-designed vaccine against Staphylococcus aureus • GlobeNewswire Inc. • 07/31/2023 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/11/2023 01:14:39 PM
- Evaxion’s AI technology identifies cancer vaccine targets associated with longer progression-free survival of melanoma patients in the EVX-01 Phase 1 clinical trial • GlobeNewswire Inc. • 06/03/2023 09:00:00 PM
- Evaxion Announces Business Update and First Quarter 2023 Financial Results • GlobeNewswire Inc. • 05/31/2023 12:30:00 PM
- Evaxion announces promising clinical Phase 1 data for its personalized cancer vaccine EVX-01 • GlobeNewswire Inc. • 05/25/2023 09:00:00 PM
Green Egg to launch $150 million bond offer for quicklime products production kiln plant Sep 22, 2023 12:11 PM
Nate's Food Co. Announces Reverse Merger and Change of Control with JP Energy Group to Drive Global Expansion • NHMD • Sep 22, 2023 9:00 AM
Trio Petroleum Corp Provides Update on Testing of the HV-1 Discovery Well • TPET • Sep 21, 2023 9:38 AM
Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation • GNPX • Sep 20, 2023 8:45 AM
Caduceus Provides Update on Its Plans for The Second Half of The Fiscal Year • CSOC • Sep 20, 2023 8:26 AM
RESILIENT ENERGY INC. (RENI) PURSUING ACQUISITION TARGETS • RENI • Sep 19, 2023 10:30 AM